PAR 11.1% 30.0¢ paradigm biopharmaceuticals limited..

FA bagger potential, page-52

  1. 21 Posts.
    lightbulb Created with Sketch. 5
    I'm still struggling to accept the fiftyonecapital report's assumption of 90% success on the phase 2 trial. That's a fairly bold statement.

    The phase 1 trials should have been somewhat expected as similar studies have been done before. Also, i didn't see any mention about any results so far relative to a placebo group.
    In saying that ,I haven't spent a huge amount of time on this so i hope i'm wrong as we can continue to ride the wave. DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.030(11.1%)
Mkt cap ! $82.30M
Open High Low Value Volume
27.5¢ 30.0¢ 27.5¢ $447.9K 1.554M

Buyers (Bids)

No. Vol. Price($)
4 257067 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 139039 6
View Market Depth
Last trade - 12.59pm 22/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.